https://arstechnica.com/tech-policy/2021/09/elizabeth-holmes-lied-to-investors-about-pharma-company-validation-prosecutors-say/

A scientist who worked at a Theranos partner said that her company did not “comprehensively validate” the diagnostic startup’s proprietary devices, undermining a claim that founder Elizabeth Holmes allegedly made to investors.

Victoria Sung had been tasked with evaluating Theranos’ Edison device for her employer, Celgene, which had a small contract with the startup. What she saw suggested that the device was not ready for use with patients.